The research interest of the Centre for Interstitial Lung Diseases in West Denmark is mainly in interstitial lung diseases such as idiopathic pulmonary fibrosis, rare lung diseases and lung diseases complicated by  pulmonary hypertension. 

Among current studies are:

The Danish Interstitial Lung Disease Registry is a national multi-centre prospective registry with data on all Danish patients with ILD  concerning referral patterns and diagnosis, diagnostic investigations and results, primary and re-evaluated diagnoses, treatment including side-effects, long-term safety and long-term outcome, follow-up patterns, comorbiditites, hospitalisations, health economics, mortality and pulmonary hypertension (Andersen et al Resp Med 2012 PMID 23034317, Resp Med 2012 22425136). The department has also taken a Nordic initiative to collaborate with other lung fibrosis centres  to develop a Nordic registry for these patients.Research on the prognostic value of HRCT scoring, the connection between smoking and lung fibrosis and socioeconomics studies are performed.

In a close cooperation with the Department of Cardiology and Department of Pharmacology, the department contributes to research on the incidence/prevalence of pulmonary hypertension among lung patients (COPD, lung fibrosis, sarcoidosis), the value of different biomarkers and echocardiographic screening.

Very rare lung diseases are also of interest such as e.g. pulmonary alveolar proteinosis (ref Leth et al 2013 Respirology PMID 23036113) and PhD studies are performed on pulmonary alveolar microlithiasis and tracheomalacia.

Research in patients with pulmonary fibrosis and sarcoidosis initiated by pharmaceutical companies are also carried out.

 

Contacts

Elisabeth Bendstrup, MD, PhD, Consultant, Associate Professor, Specialist in Respiratory Medicine, karbends@rm.dk
Ole Hilberg, MD, PhD, DmSc, Consultant, Associate Professor, Specialist in Respiratory Medicine, olehilbe@rm.dk